David Kerr (oncologist)

David James Kerr

CBE, MA MD DSc FRCP (Glas & Lon) FRCGP (Hon) FMedSci
David James Kerr; CBE, MA MD DSc FRCP (Glas & Lon) FRCGP (Hon) FMedSci
Born	1956; Glasgow, Scotland
Nationality	British
Education	University of Glasgow – MD (1987), BSc-Biochemistry (1977)
Years active	1992-present
Known for	Research and Treatment of colorectal cancer; Gene Therapy
	Medical career
Profession	Medical Doctor, researcher
Field	Oncology
Institutions	Oxford University
Research	Colorectal Cancer, Gene Therapy
Awards	Distinguished Harvard Global Health Catalyst Award (2017); Honorary Fellowship of the Royal College of General Practitioners (2007); European Society for Medical Oncology Award(2006); Commander of the Order of the British Empire (2002); NHS Nye Bevan Award for Innovation (2000); European School of Oncology International Award for outstanding contribution to chemotherapy research (1987);

Professor David James Kerr CBE (born 1956, Glasgow) is a British Cancer Researcher. His primary area of research is treatment and management of colorectal cancer.

He served as Chief Research Advisor at Sidra Medical and Research Center in Doha, Qatar. David James Kerr is Professor of Cancer Medicine and Former Fellow of Corpus Christi College, Oxford. He was also President-Elect for European Society for Medical Oncology (2009).

David James Kerr’s clinical research into adjuvant therapy of early-stage colorectal cancer has contributed to saving thousands of lives over the past two decades.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.